ASTRO 骨转移外照射指南：疼痛、脊柱风险与再照射问题
类型: 放疗指南 / 骨转移支持治疗 发表日期: 2024-05-22 入库日期: 2026-05-21 来源: PubMed / ASTRO / Practical Radiation Oncology 标签: 骨转移, 放疗, ASTRO, SBRT, 疼痛控制, 脊柱, 胸骨, 再照射
Citation
Alcorn S, et al. External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline. Practical Radiation Oncology. 2024. PMID: 38788923. DOI: 10.1016/j.prro.2024.04.018
ASTRO guideline page: Bone Metastases Guideline
Why it matters for mom
Mom has bone-dominant metastatic disease, including a clinically important sternum/parasternal soft-tissue lesion. This guideline is not EGFR-specific, but it is directly relevant to the radiation oncology questions the family should ask: pain prevention, structural risk, spinal cord/cauda equina risk, conventional palliative RT versus SBRT, and whether re-irradiation is feasible.
Practical takeaways
- Radiation can be for pain palliation, structural-risk control, local tumor control, or neurologic emergency prevention. The goal should be named clearly.
- SBRT may be considered in selected patients, but conventional palliative schedules remain standard and often appropriate.
- For spine or weight-bearing bone lesions, radiation planning should coordinate with orthopedic/neurosurgical assessment when stability is a concern.
- Denosumab reduces skeletal-related-event risk but does not replace local therapy for a threatening or painful lesion.
Questions for radiation oncology
- Is the sternum/parasternal lesion being treated for pain, local control, fracture/structural risk, biopsy planning, or prevention?
- Would conventional RT or SBRT be more appropriate for this site and goal?
- Are there any spine, pelvis, or weight-bearing lesions needing proactive review even if symptoms are mild?
- Would radiation interfere with future biopsy, NGS, or clinical trial eligibility?